FAIR Health Releases Annual Update of Opioid Tracker, an Interactive Tool Tracking Opioid Use Disorder Nationally and State by State

NEW YORK, Oct. 14, 2026 /PRNewswire/ — Commercially insured patients with diagnoses of opioid use disorder increased 32.7 percent nationally from 2022 to 2025, according to FAIR Health’s Opioid Tracker. In 2022, there were 449 patients with opioid use disorder diagnoses per 100,000 patients, while in 2025, there were 596. This and other findings were reported today when FAIR Health released its annual update of the Opioid Tracker, a free, interactive tool tracking opioid use disorder among commercially insured patients nationally and state by state. A brief released simultaneously offers a user’s guide to the Opioid Tracker.

The Opioid Tracker includes a heat map representing patients with opioid use disorder diagnoses per 100,000 patients receiving medical services in 2025 for each state. Clicking on a state displays an infographic for that state with opioid use disorder data from 2025. The infographic includes the top five procedure code categories by utilization, the top five procedure codes by aggregate allowed amounts,¹ the change in the number of patients with opioid use disorder diagnoses per 100,000 patients from 2022 to 2025, and the distribution of patients by age and gender. There is also a similar infographic for the nation as a whole, along with a second national infographic showing the top five states for opioid use disorder diagnoses, the fastest-growing specialties, the distribution of places of service, and service type (professional versus facility) as a percentage of total allowed amounts. The source of the data is FAIR Health’s repository of commercial health claims.

Among the key findings revealed by the Opioid Tracker:

• In 2025, Tennessee had the highest rate of commercially insured patients receiving treatment for opioid use disorder, with 1,551 patients with such a diagnosis per 100,000 patients (compared to 596 patients per 100,000 nationally). It was followed by West Virginia (1,528 patients), Mississippi (1,373 patients), Arkansas (1,320 patients) and Delaware (1,256 patients).
• Nationally in 2025, alcohol/substance abuse services and treatments constituted the procedure code category with the highest utilization for opioid use disorder among commercially insured patients, representing 39.0 percent of all claim lines² with an opioid use disorder diagnosis.
• Nationally in 2025, G2067 (medication-assisted treatment, methadone, weekly bundle) was the procedure code with the highest aggregate allowed amount for opioid use disorder among commercially insured patients, accounting for 9.4 percent of aggregate allowed amounts for that diagnosis. The average allowed amount for this code was $243.
• The highest percentage of opioid use disorder diagnoses among commercially insured patients were attributable to patients in the 41 to 50 age group, with 28.1 percent of the total age distribution in 2025 across the nation.
• Among commercially insured patients with opioid use disorder diagnoses nationally in 2025, males were 56.1 percent of patients with those diagnoses, while females were 43.9 percent.
• The fastest-growing specialty involved in the treatment of opioid use disorder nationally in 2025 was nurse practitioner, which increased 67 percent in percent of claim lines from 2022 to 2025. In second and third positions, respectively, were psychiatric nurse (47 percent) and emergency medicine (44 percent).

For the Opioid Tracker, click here. For the user’s guide to the Opioid Tracker, click here.

Follow us on X @FAIRHealth

About FAIR Health

FAIR Health’s mission is to supply objective, unbiased information for all stakeholders to improve healthcare quality, access and affordability. It holds the nation’s largest collection of commercial healthcare claims data, which is growing at a rate of more than five billion validated medical services a year. A national Qualified Entity certified by CMS, FAIR Health also receives all claims for individuals enrolled in traditional Medicare Parts A, B and D. As a testament to its reliability and objectivity, FAIR Health’s data products—including pricing benchmarks and custom analytics—are widely used by commercial insurers and self-insurers, providers, hospitals and healthcare systems, government, researchers and more. FAIR Health has been designated an official data source for state health programs, including workers’ compensation and personal injury protection (PIP) programs, and surprise billing laws that protect consumers. FAIR Health’s free consumer website and mobile app, available in English and Spanish, enable consumers to estimate and plan for their healthcare expenses and offer a rich educational platform on health insurance. The website has been honored by the White House Summit on Smart Disclosure, the Agency for Healthcare Research and Quality (AHRQ), URAC, the eHealthcare Leadership Awards, appPicker, Employee Benefit News and Kiplinger’s Personal Finance. FAIR Health is a national, 501(c)(3) nonprofit organization. For more information on FAIR Health, visit fairhealth.org.

Contact:
Rachel Kent
Executive Director of Communications and Marketing
FAIR Health
646-396-0795
rkent@fairhealth.org

¹ An allowed amount is the total negotiated, in-network fee paid to the provider under an insurance plan. It includes the amount that the health plan pays and the part the patient pays under the plan’s in-network cost-sharing provisions (e.g., copay or coinsurance if the patient has met the deductible). The aggregate allowed amount for a given procedure is simply the sum of all the allowed amounts for that procedure in the applicable geographic area during the time frame.

² A claim line is an individual service or procedure listed on an insurance claim.

View original content to download multimedia:https://www.prnewswire.com/news-releases/patients-with-opioid-use-disorder-diagnoses-increased-almost-33-percent-from-2022-to-2025-302908107.html

SOURCE FAIR Health